pubmed-article:8787447 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:8787447 | lifeskim:mentions | umls-concept:C0086661 | lld:lifeskim |
pubmed-article:8787447 | lifeskim:mentions | umls-concept:C0007131 | lld:lifeskim |
pubmed-article:8787447 | lifeskim:mentions | umls-concept:C0078974 | lld:lifeskim |
pubmed-article:8787447 | lifeskim:mentions | umls-concept:C1514485 | lld:lifeskim |
pubmed-article:8787447 | pubmed:issue | 6 | lld:pubmed |
pubmed-article:8787447 | pubmed:dateCreated | 1996-9-24 | lld:pubmed |
pubmed-article:8787447 | pubmed:abstractText | Mutation or deregulation of certain cellular genes (protooncogenes) results in expression of proteins that appear to promote malignant transformation. Human non-small cell lung cancer has been documented to express many such oncogenes including c-myc, bcl-2, and mutant p53. Antisense oligodeoxyribonucleotides (ASODN) complementary to these oncogenes were tested on three non-small cell lung cancer cell lines for their efficacy in inhibiting cellular proliferation and oncoprotein expression. | lld:pubmed |
pubmed-article:8787447 | pubmed:language | eng | lld:pubmed |
pubmed-article:8787447 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8787447 | pubmed:citationSubset | AIM | lld:pubmed |
pubmed-article:8787447 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8787447 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8787447 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8787447 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:8787447 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:8787447 | pubmed:month | Dec | lld:pubmed |
pubmed-article:8787447 | pubmed:issn | 0003-4975 | lld:pubmed |
pubmed-article:8787447 | pubmed:author | pubmed-author:SmithL JLJ | lld:pubmed |
pubmed-article:8787447 | pubmed:author | pubmed-author:RobinsonL ALA | lld:pubmed |
pubmed-article:8787447 | pubmed:author | pubmed-author:KayH DHD | lld:pubmed |
pubmed-article:8787447 | pubmed:author | pubmed-author:FontaineM PMP | lld:pubmed |
pubmed-article:8787447 | pubmed:author | pubmed-author:PirruccelloS... | lld:pubmed |
pubmed-article:8787447 | pubmed:author | pubmed-author:MountjoyC PCP | lld:pubmed |
pubmed-article:8787447 | pubmed:issnType | Print | lld:pubmed |
pubmed-article:8787447 | pubmed:volume | 60 | lld:pubmed |
pubmed-article:8787447 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:8787447 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:8787447 | pubmed:pagination | 1583-91 | lld:pubmed |
pubmed-article:8787447 | pubmed:dateRevised | 2005-11-17 | lld:pubmed |
pubmed-article:8787447 | pubmed:meshHeading | pubmed-meshheading:8787447-... | lld:pubmed |
pubmed-article:8787447 | pubmed:meshHeading | pubmed-meshheading:8787447-... | lld:pubmed |
pubmed-article:8787447 | pubmed:meshHeading | pubmed-meshheading:8787447-... | lld:pubmed |
pubmed-article:8787447 | pubmed:meshHeading | pubmed-meshheading:8787447-... | lld:pubmed |
pubmed-article:8787447 | pubmed:meshHeading | pubmed-meshheading:8787447-... | lld:pubmed |
pubmed-article:8787447 | pubmed:meshHeading | pubmed-meshheading:8787447-... | lld:pubmed |
pubmed-article:8787447 | pubmed:meshHeading | pubmed-meshheading:8787447-... | lld:pubmed |
pubmed-article:8787447 | pubmed:meshHeading | pubmed-meshheading:8787447-... | lld:pubmed |
pubmed-article:8787447 | pubmed:meshHeading | pubmed-meshheading:8787447-... | lld:pubmed |
pubmed-article:8787447 | pubmed:meshHeading | pubmed-meshheading:8787447-... | lld:pubmed |
pubmed-article:8787447 | pubmed:meshHeading | pubmed-meshheading:8787447-... | lld:pubmed |
pubmed-article:8787447 | pubmed:year | 1995 | lld:pubmed |
pubmed-article:8787447 | pubmed:articleTitle | c-myc antisense oligodeoxyribonucleotides inhibit proliferation of non-small cell lung cancer. | lld:pubmed |
pubmed-article:8787447 | pubmed:affiliation | Division of Cardiovascular and Thoracic Surgery, University of South Florida, H. Lee Moffitt Cancer Center and Research Institute, Tampa 33612-9497, USA. | lld:pubmed |
pubmed-article:8787447 | pubmed:publicationType | Journal Article | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8787447 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8787447 | lld:pubmed |
http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:8787447 | lld:pubmed |